Invion (AU:IVX) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Invion Limited has issued over half a million new shares and is in talks with RMW Cho Group Limited to potentially expand its Photosoft™ technology rights. Known for advancing photodynamic therapy for cancer treatment, Invion is leveraging its ASX listing to drive innovation in the medical field. These developments could impact the company’s market position and attract investor interest.
For further insights into AU:IVX stock, check out TipRanks’ Stock Analysis page.